Results 151 to 160 of about 613,285 (267)

Lingual Retainer Stabilized by Modifying Archwire

open access: yesJournal of Indian Orthodontic Society, 2013
Shreenivas S Astekar   +3 more
doaj   +1 more source

Bone-Modifying Agents in Metastatic Castration-Resistant Prostate Cancer.

open access: yesJAMA Netw Open
Ozay ZI   +14 more
europepmc   +1 more source

SGLT2 Inhibition as a Novel Therapeutic Strategy in Rheumatic Heart Disease. [PDF]

open access: yesJACC Asia
Morel O   +8 more
europepmc   +1 more source

Liquid biopsy‐based diagnostic evaluation of hypermethylated CpG sites for ovarian cancer diagnosis

open access: yesMolecular Oncology, EarlyView.
This schematic outlines the workflow from biomarker identification to duplex MethyLight assay validation for epithelial ovarian cancer diagnosis using cfDNA‐based liquid biopsy. Initial screening of hypermethylated CpG candidates (cg02957270, cg10061138 cg00480298, COL2A1) was performed in tissue using ARMS‐PCR, COBRA, qPCR and image analysis. Selected
Deepa Bisht   +3 more
wiley   +1 more source

Leukotriene-modifying agent chemoprophylaxis for severe influenza illness: a multi-approach study. [PDF]

open access: yesAm J Epidemiol
Snyder BM   +10 more
europepmc   +1 more source

Loss of proton‐sensing TDAG8 increases tumor progression in mouse models of colon cancer

open access: yesMolecular Oncology, EarlyView.
Loss of the pH‐sensing receptor TDAG8 accelerates colorectal cancer progression in mice. Animals lacking TDAG8 expression had increased tumor growth, DNA damage, and recruitment of tumor‐associated immune cells, including macrophages, neutrophils, and monocytes.
Ermanno Malagola   +11 more
wiley   +1 more source

Epigenetic heterogeneity and plasticity in therapy‐induced tumor states through single‐cell multi‐omics

open access: yesMolecular Oncology, EarlyView.
Single‐cell multi‐omics reveals epigenetic heterogeneity across therapy‐adaptive tumor states, including quiescent/dormant, drug‐tolerant persister, and EMT‐like phenotypes. By linking regulatory features with state‐associated biomarkers, these approaches inform biomarker‐guided therapeutic strategies for evolving tumors.
Hee Jung Kim   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy